Evidence map›Paper›PMID 42910555›Full record

ArticleStatistics in medicine2026

Which Small-Sample Correction Should be Used When Analyzing Stepped-Wedge Designs With Time-Varying Treatment Effects?

Yongdong Ouyang, Monica Taljaard, James P Hughes, Fan Li

Abstract read
In one paragraph

Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yongdong OuyangDepartment of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.ORCID https://orcid.org/0000-0002-8692-2991
Monica TaljaardMethodological and Implementation Research, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID https://orcid.org/0000-0002-3978-8961
James P HughesDepartment of Biostatistics, School of Public Health, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0001-5034-3157
Fan LiDepartment of Biostatistics, Yale University, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0001-6183-1893

Funding

NIH HHS AI029168Patient-Centered Outcomes Research Institute ME-2022C2-27676
6 · The paper itself

Abstract

Stepped-wedge cluster randomized trials (SW-CRTs) evaluate interventions that are sequentially rolled out across clusters. Standard analyses of SW-CRTs typically use immediate-treatment (IT) models, which assume the treatment effects begin at crossover and remain constant thereafter. When treatment effects vary with exposure duration, IT models may misrepresent the target effects. Exposure-time indicator (ETI) models address this by allowing treatment effects to differ by time since exposure and can properly target the time-averaged treatment effect (TATE) and long-term effect (LTE). Like IT models, ETI models require specification of a random-effects structure, which may be misspecified. While robust variance estimators (RVEs) theoretically protect against such misspecification, their empirical performance under ETI models is not well understood. We review RVEs for ETI models and evaluate them in comprehensive simulation studies with continuous and binary outcomes under correctly specified (binary only) and misspecified random-effects structures. We compare the classic sandwich variance, Kauermann-Carroll (KC), Mancl-DeRouen (MD), and Morel-Bokossa-Neerchal (MBN) bias-corrected sandwich variance estimators for inference on the TATE and LTE in primary simulations and additionally evaluate Fay-Graubard (FG) in a sub-study. Our simulations show that under misspecified random-effects structures, model-based standard errors (SE) produced undercoverage, whereas RVEs improved performance under the ETI models. For continuous outcomes, MD with a t-distribution and degrees of freedom equal to the number of clusters minus two gave the closest to nominal coverage probabilities. Surprisingly, however, MBN was the only consistently reliable option for binary outcomes. MD, however, could be unstable in one-cluster-per-sequence designs because of data sparsity. Across scenarios, both model-based SE and RVE for LTE were unstable, indicating that greater caution is needed when targeting LTE under ETI models.

Indexed as

Models, StatisticalRandomized Controlled Trials as TopicCluster AnalysisComputer SimulationHumansSample SizeTime Factorsbias‐corrected sandwich variance estimatorcluster randomized trialsexponential decaygeneralized linear mixed‐effects modelsmall‐sample correctiontime‐varying treatment effects

Identifiers

PMID42910555
PMCPMC13688418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.